Cost-effectiveness analysis of escitalopram in the treatment of major depressive disorder in Turkey

被引：0
|
作者：
Hemels, ME
Karamustafyoglu, O
Ozmen, E
Dilsad, S
Mene, S
机构：
[1] H Lundbeck & Co AS, Paris, Il De France, France
[2] Lundbeck Ilac Ticaret Ltd, Istanbul, Ilac, Turkey
[3] Marmara Univ, Istanbul, Turkey
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63061-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany
    Kulp, W
    Hemels, M
    Greiner, W
    Graf, VDJ
    VALUE IN HEALTH, 2005, 8 (06) : A210 - A210
  • [2] A cost-effectiveness analysis of escitalopram and sertraline in the treatment of major depressive disorder
    Armstrong, EP
    Skrepnek, GH
    Malone, DC
    Erder, H
    VALUE IN HEALTH, 2005, 8 (03) : 393 - 393
  • [3] Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
    Mencacci, Claudio
    Di Sciascio, Guido
    Katz, Pablo
    Ripellino, Claudio
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 87 - 99
  • [4] Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder
    Fantino, Bruno
    Moore, Nicholas
    Verdoux, Helene
    Auray, Jean-Paul
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 107 - 115
  • [5] Cost-effectiveness of Escitalopram vs. Venlafaxin XR in the treatment of major depressive disorder in Germany
    Kulp, W
    Greiner, W
    Schulenburg, JM
    VALUE IN HEALTH, 2005, 8 (03) : 392 - 393
  • [6] Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria
    Hemels, MEH
    Kasper, S
    Walter, E
    Einarson, TR
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (06) : 869 - 878
  • [7] Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine in Major Depressive Disorder
    Despiegel, Nicolas
    Marteau, Florence
    Danchenko, Natalya
    Linne, Agneta Bjorck
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S12 - S12
  • [8] Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder
    Xie, Feng
    Despiegel, Nicolas
    Danchenko, Natalya
    Hansen, Karina
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 (01) : 59 - 69
  • [9] Cost-Effectiveness of Escitalopram in Major Depressive Disorder in the Dutch Health Care Setting
    Nuijten, Mark J. C.
    Brignone, Melanie
    Marteau, Florence
    den Boer, Johan A.
    Hoencamp, Erik
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1364 - 1378
  • [10] COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY
    Tatar, M.
    Dilbaz, N.
    Oral, E. T.
    Tan, M.
    VALUE IN HEALTH, 2012, 15 (04) : A88 - A88
12345